DAX6.281-1,8%  Dow12.420-1,3%  Euro1,23740,0% 
ESt502.116-2,0%  Nas2.837-1,2%  Öl103,30,0% 
TDax751,1-1,8%  Nikkei8.477-1,8%  Gold1.5630,0% 
Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyHome
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden/Drucken
HistorischRealtime PushmyNews neu IR-DatenAnleihen
handeln

08.02.2011 22:06

Senden

National Research Corporation Announces Fourth Quarter and Year-End 2010 Results

National Research zu myNews hinzufügen Was ist das?


National Research Corporation (NASDAQ:NRCI) today announced results for the fourth quarter and year-end 2010.

Fourth Quarter:

  • Revenue $15.9 million up 15%
  • Net income $1.6 million down 30%
  • Diluted earnings per share $0.23 down 30%
  • Net new contracts signed reached $5.1 million, up 80%

Year-end 2010

  • Revenue $63.4 million up 10%
  • Net income $8.5 million; diluted earnings per share $1.26
  • Net new contracts signed up 80%; total contract value up 22%

Commenting on the fourth quarter results, Michael D. Hays, president and chief executive officer of National Research Corporation, said, "We accelerated our investment in growth opportunities during the fourth quarter in light of favorable conditions for Illuminate and our new subscription-based offerings from NRC Picker, The Governance Institute and My InnerView. We also continued sales force expansion. The returns from these investments are continuing to materialize in the form of increased sales and sustainable points of differentiation in the marketplace.”

Revenue for the quarter ended December 31, 2010, increased 15% to $15.9 million, compared to $13.8 million for the same period in 2009. Net income for the fourth quarter was $1.6 million or $0.24 basic and $0.23 diluted earnings per share, compared with net income of $2.2 million or $0.34 basic and $0.33 diluted earnings per share, in the prior year period.

Revenue for the year ended December 31, 2010, was $63.4 million, compared to $57.7 million for the same period in 2009, an increase of 10%. Net income for the years ended December 31, 2010 and 2009, was $8.5 million or $1.28 basic and $1.26 diluted earnings per share.

In closing, Patrick E. Beans, chief financial officer of National Research Corporation, said, "The Company clearly diverted from historical patterns by reinvesting all its incremental earnings for the full year 2010 over 2009. To provide visibility related to the anticipated return on these investments, today we are announcing earnings guidance of $1.65 per dilutive share for the year ending December 31, 2011.”

The Company’s Board of Directors has declared a regular quarterly cash dividend of $0.22 (twenty-two cents) per share, an increase of 16% over the prior quarter, payable March 31, 2011, to shareholders of record as of the close of business on March 4, 2011.

A listen-only simulcast of National Research Corporation’s 2010 fourth quarter and year-end conference call will be available online at www.earnings.com on February 9, 2011, beginning at 11:00 a.m. Eastern time. The online replay will follow approximately one hour later and continue for 30 days.

National Research Corporation, headquartered in Lincoln, Nebraska, is a leading provider of performance measurement, improvement services, and governance education to the healthcare industry in the United States and Canada.

This press release includes "forward-looking” statements related to the Company that can generally be identified as describing the Company’s future plans, objectives or goals. Such forward-looking statements are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the factors that could affect the Company’s future results, please see the Company’s filings with the Securities and Exchange Commission.

 

NATIONAL RESEARCH CORPORATION

Unaudited Consolidated Statements of Operations

(In thousands, except per share data)

           

Three Months Ended

Twelve Months Ended

December 31,

December 31,

 

2010

   

2009

   

2010

   

2009

 
 
Revenue $ 15,883 $ 13,842 $ 63,398 $ 57,692
 
Operating expenses:
Direct expenses 6,265 5,386 24,635 24,148
Selling, general and administrative 5,937 4,204 20,202 16,016
Depreciation and amortization 1,322 928 4,704 3,831
Total operating expenses   13,524     10,518     49,541   43,995  
 
Operating income 2,359 3,324

 

13,857 13,697
 
Other income (expense):
Interest income 1 -- 6 2
Interest expense (163 ) (90 ) (491 ) (405 )
Other, net   (39 )   (45 )   (57 )   (177 )
 
Total other income (expense) (201 ) (135 ) (542 ) (580 )
 
Income before income taxes 2,158 3,189 13,315 13,117
Provision for income taxes   590     951     4,816     4,626  
 
Net income $ 1,568   $ 2,238   $ 8,499   $ 8,491  
 
Net income per share, basic $ 0.24   $ 0.34   $ 1.28   $ 1.28  
Net income per share, diluted $ 0.23   $ 0.33   $ 1.26   $ 1.26  
 
Weighted average shares outstanding:
Basic 6,644 6,639 6,637 6,637
Diluted 6,780 6,725 6,736 6,723
 
   

NATIONAL RESEARCH CORPORATION

Unaudited Consolidated Condensed Balance Sheets

(Dollars in thousands)

 

Dec. 31,

Dec. 31,

2010

2009

ASSETS
 
Current Assets:
Cash and cash equivalents $ 3,519 $ 2,512
Accounts receivable, net 9,172 5,214
Income taxes recoverable 1,277 803
Other current assets   3,373     3,135  
Total current assets 17,341 11,664
 
Net property and equipment 14,482 13,975
Other, net   63,793     46,860  
 
Total Assets $ 95,616   $ 72,499  
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
 
Current Liabilities:
Accounts payable and accrued expenses $ 2,307 $ 1,446
Deferred revenue 17,701 11,907
Accrued compensation 4,161 1,926
Notes payable   1,827     816  
Total current liabilities 25,996 16,095
 
Non-current liabilities   21,036     12,233  
 
Total Liabilities   47,032     28,328  
 
Shareholders’ Equity:
Common stock, $0.001 par value; 20,000,000 shares authorized;
issued 8,044,855 in 2010 and 8,018,044 in 2009;
outstanding 6,668,574 in 2010 and 6,662,111 in 2009 8 8
Additional paid-in capital 28,970 27,871
Retained earnings 41,343 37,905
Accumulated other comprehensive income (loss) 1,108 769
Treasury stock   (22,845 )   (22,382 )
Total shareholders’ equity   48,584     44,171  
 
Total liabilities and shareholders’ equity $ 95,616   $ 72,499  

Kommentare zu diesem Artikel

Geben Sie jetzt einen Kommentar zu diesem Artikel ab.
 Kommentar hinzufügen 
  • Relevant
  • Alle
  • vom Unternehmen
  • Sprache:
  • Alle
  • DE
  • EN
  • Sortieren:
  • Datum
  • meistgelesen
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar
Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar
Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar
Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar
Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar
Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen
Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen
vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

National Research Corp. zu myNews hinzufügen Was ist das?
  • Alle
  • Buy
  • Hold
  • Sell
Keine Analysen gefunden.

AKTIEN IN DIESEM ARTIKEL

ANZEIGE

National Research Peer Group News

Keine Nachrichten gefunden.

ANZEIGE

Was halten Sie von nutzergenerierten Chartanalysen auf finanzen.net?
Ich würde liebend gerne mein Wissen über Chartanalyse dem Publikum von finanzen.net zur Verfügung stellen.
Ich kenne mich bei Chartanalyse nicht so gut aus, halte nutzergenerierte Chartanalysen aber für einen echten Mehrwert.
Ich halte nichts von den Methoden der Chartanalyse und habe deshalb auch kein Interesse an nutzergenerierten Analysen.
 Abstimmen